More recently, it has been reported in melanoma that PAK4 expression was elevated in the patients’ samples with poor infiltrated immune cells and thus decreased the response to a PD-1 blockade, and that knockout of PAK4 enhanced the infiltration of CD8+ T cells, possibly by downregulation of PD-L1 [139]. The gene discussed is CD8A; the disease is melanoma.